Creating materials for testing new influenza vaccines
Task V32: Manufacture of Influenza Virus Human Challenge Material for Phase I/II Clinical Testing
This study is working on creating and improving materials for new flu vaccines, which could help keep you and others safer from the flu and similar illnesses.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Idt Biologika Gmbh NIH-funded |
| Lab location | 1 site (Dessau-Rosslau, Germany) |
| Project ID | NIH-11167540 on NIH RePORTER |
What this research studies
This research focuses on the production and characterization of materials needed for clinical testing of influenza vaccines. It involves planning and optimizing vaccine development, ensuring compliance with manufacturing standards, and providing regulatory support for submissions to the FDA. Patients may benefit from the development of new vaccines that could improve protection against influenza and related infectious diseases. The research aims to facilitate the introduction of innovative vaccines and biologics.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals at risk for influenza or those who may require vaccination.
Not a fit: Patients who are not at risk for influenza or those who have contraindications to vaccination may not receive benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of more effective influenza vaccines, enhancing patient protection against the virus.
How similar studies have performed: Other research has shown success in developing vaccines through similar manufacturing and testing approaches, indicating a promising path for this project.
Where this research is happening
Dessau-Rosslau, Germany
- Idt Biologika Gmbh — Dessau-Rosslau, Germany (Active)
Researchers
- Principal investigator: Singh, Suneel — Idt Biologika Gmbh
- Study coordinator: Singh, Suneel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.